Latest Cost Management News

Adore Beauty delivered record FY26 revenue of $207.3 million, driven by retail expansion and owned brands, while posting a statutory loss amid heavy investment. The Group targets 10%+ revenue growth and a sharp EBITDA increase in FY27 as its omni-channel strategy matures.

Capral Limited posted a solid first half for 2026 with revenue rising 14% on higher aluminium prices and volume growth, while earnings remained steady despite cost pressures and subdued residential demand.

Liberty Financial Group delivered a 7.8% rise in net profit after tax to $143.8 million for FY26, underpinned by record loan originations and stable credit quality. The group declared a fully franked 15 cent special dividend payable in September 2026.

Chorus reported solid FY26 results with revenue growth driven by fibre expansion and disciplined cost management, while accelerating copper network retirement and launching new digital infrastructure services.

Beam Communications (ASX:BCC) swung from a $13.5 million loss in FY25 to a $14.3 million profit in FY26, driven by the divestment of Zoleo and a return to EBITDA profitability in its core operations. The company declared a one-off $1.2 million unfranked dividend and doubled its cash reserves to $3.7 million.

ARN Media posted a $28.3 million net loss for the half-year to June 2026, hit by a $25 million impairment and legal settlements, while digital revenue grew and cost savings accelerated.

TPG Telecom posted a steady half-year with 3.1% mobile revenue growth offsetting broadband declines, delivering 1% EBITDA growth and declaring a 10 cent dividend.

Pacific Edge’s draft Medicare Local Coverage Determination for its Cxbladder bladder cancer tests marks a pivotal step toward unlocking a $10.2 billion global market. Despite FY26 setbacks, the company is poised for growth with improved reimbursement prospects and strategic cost management.

Servcorp Limited delivered a record FY26 with a 24% rise in underlying NPBIT to $87 million, boosted dividends by 14%, and outlined a cautious yet optimistic FY27 growth strategy.

Medical Developments International (ASX:MVP) reported a 9% revenue increase to $42.6 million and a 566% jump in net profit to $0.6 million for FY26, driven by robust growth in its Pain Management segment and expanded paediatric approvals in Europe.

Cuscal Limited reported a 49% jump in statutory profit after tax to $42.7 million for FY26, driven by strategic acquisitions of Indue and Paymark that expanded its Australian and New Zealand footprint. The company declared a fully franked 7-cent final dividend and expects mid-twenties percentage growth in underlying profit and transaction volumes for FY27.

Brambles Limited posted a 6% rise in sales revenue to US$7.04 billion for FY26, navigating US repair bottlenecks with decisive investments and reaffirming growth targets for FY27 and beyond.